Sources

7 Total Sources

FDA-Approved GLP-1 Drugs Offer Obesity Option for U.S. Adolescents 12+ as 1 in 5 Children Are Affected

Loma Linda University4d ago

Pediatric Endocrinologist Discusses GLP-1 Medications for Childhood Obesity in Adolescents 12+

New York Post 4d ago

Exclusive | Meet the parents putting their kids on Ozempic

ijpsjournal.com4d ago

Next Generation Incretin Therapies in Obesity: Evolution for Multi-Receptor Agonism to Non-Peptide Oral Molecules | IJPS Journal

National Institutes of Health (NIH) (.gov)4d ago

Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation - PMC

droracle.ai4d ago

Can a 12-year-old receive GLP-1 receptor agonist injections for type 2 diabetes or obesity?

lifeendo.com4d ago

Houston Pediatric Weight Loss: Physician-Led Care for Kids & Teens

An expanding body of research indicates that these anti-obesity drugs may also work for the disorder known as PMOS